FDA accepts NDA re Jardiance® for kidney disease
Boehringer Ingelheim and Eli Lilly and Company announced that the FDA has accepted a supplemental New Drug Application for Jardiance® (empagliflozin) tablets. The tablets are being investigated as...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Boehringer Ingelheim and Eli Lilly and Company announced that the FDA has accepted a supplemental New Drug Application for Jardiance® (empagliflozin) tablets. The tablets are being investigated as...
In an effort to practice precision medicine — a medical movement to develop specific treatments for individual patients — scientists created software to quantify and...
BioXcel Therapeutics reports promising top-line data from its Phase 2 trial of BXCL701, the Company’s investigational, oral innate immune activator, in combination with KEYTRUDA® (pembrolizumab) in small...
BioCT and Connecticut’s biotechnology partners are thrilled to announce Connecticut’s 2023 Pavilion at the BIO International Convention showcasing the state’s growing life sciences industry to the global biotechnology...
More than three years after being merged into a Salt Lake City-based company, a Monroe medical components manufacturer has added 80 jobs in the past...
Construction is currently underway for the first phase of a project at the site of the former Coliseum in New Haven at Orange Street and Frontage...
The Connecticut Business & Industry Association, the state’s largest business lobby, has announced its 2023 legislative agenda, which focuses on addressing Connecticut’s workforce shortage and...
Torigen Pharmaceuticals of Farmington, CT, has entered into a preferred partnership agreement with VerticalVet of Cornelius, NC, to provide the VerticalVet group purchasing Organization access to Torigen....
The University of Connecticut is joining five other colleges and universities to raise money for cancer research. UConn Health will use its part of the money to...